Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Lifevantage Corp (LFVN)

Lifevantage Corp (LFVN)
12.40 +0.02 (+0.16%) 04/22/25 [NASDAQ]
12.15 x 1 15.83 x 1
Realtime by (Cboe BZX)
12.15 x 1 15.83 x 1
Realtime 12.40 unch (unch) 16:00 ET
Quote Overview for Tue, Apr 22nd, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
12.31
Day High
13.78
Open 12.75
Previous Close 12.38 12.38
Volume 223,670 223,670
Avg Vol 165,670 165,670
Stochastic %K 9.31% 9.31%
Weighted Alpha +48.41 +48.41
5-Day Change -1.68 (-11.79%) -1.68 (-11.79%)
52-Week Range 5.22 - 27.38 5.22 - 27.38
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 155,381
  • Shares Outstanding, K 12,551
  • Annual Sales, $ 200,160 K
  • Annual Income, $ 2,940 K
  • EBIT $ 11 M
  • EBITDA $ 14 M
  • 60-Month Beta 0.75
  • Price/Sales 0.84
  • Price/Cash Flow 15.23
  • Price/Book 5.63

Options Overview Details

View History
  • Implied Volatility 193.01% ( +15.05%)
  • Historical Volatility 72.46%
  • IV Percentile 99%
  • IV Rank 71.34%
  • IV High 260.01% on 05/03/24
  • IV Low 26.20% on 05/20/24
  • Put/Call Vol Ratio 138.46
  • Today's Volume 3,626
  • Volume Avg (30-Day) 403
  • Put/Call OI Ratio 3.89
  • Today's Open Interest 4,757
  • Open Int (30-Day) 2,081

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +1,427,242.86%

Price Performance

See More
Period Period Low Period High Performance
1-Month
12.18 +3.20%
on 04/21/25
Period Open: 15.46
16.30 -22.88%
on 03/24/25
-2.89 (-18.69%)
since 03/21/25
3-Month
12.18 +3.20%
on 04/21/25
Period Open: 23.78
25.38 -50.47%
on 01/24/25
-11.21 (-47.14%)
since 01/22/25
52-Week
5.22 +140.80%
on 07/09/24
Period Open: 6.05
27.38 -54.09%
on 01/14/25
+6.52 (+107.77%)
since 04/22/24

Most Recent Stories

More News
LifeVantage to Announce Third Quarter Fiscal Year 2025 Results on May 6, 2025

LFVN : 12.40 (+0.16%)
LifeVantage Expands Global Reach with International Launch of the MB System™

LFVN : 12.40 (+0.16%)
LifeVantage Announces Launch of LV360 and Evolve Compensation Plan in Philippines, Taiwan, Hong Kong, and Singapore Markets

LFVN : 12.40 (+0.16%)
GLP-1 Alternatives: 2 Stocks Benefiting From Weight Loss Trends

GLP-1 weight loss drugs are in short supply enabling lab to make compounded GLP-1 treatments sold for 80% less than the name-brand drugs.

LFVN : 12.40 (+0.16%)
NVO : 59.91 (+2.71%)
HIMS : 25.35 (-1.90%)
LLY : 827.54 (+1.16%)
Lifevantage: Fiscal Q2 Earnings Snapshot

Lifevantage: Fiscal Q2 Earnings Snapshot

LFVN : 12.40 (+0.16%)
LifeVantage Declares Quarterly Dividend

LFVN : 12.40 (+0.16%)
LifeVantage Announces Financial Results for the Second Quarter of Fiscal 2025

LFVN : 12.40 (+0.16%)
LifeVantage Announces Completion of International In Vitro Study on the MB System™  

LFVN : 12.40 (+0.16%)
LifeVantage to Announce Second Quarter Fiscal Year 2025 Results on February 5, 2025

LFVN : 12.40 (+0.16%)
TrueScience® Activated Skincare Collection Recognized for Cutting-Edge Innovation, Clean Beauty Standards, and Proven Anti-Aging Results*

LFVN : 12.40 (+0.16%)
LifeVantage Welcomes Todd Thompson as Chief Information and Innovation Officer

LFVN : 12.40 (+0.16%)
LifeVantage Launches 2025 Vision with “Drive ERA” Theme and International Expansion Plans for Evolve Compensation Plan and the MindBody GLP-1 System™

LFVN : 12.40 (+0.16%)
LifeVantage Study Confirms Breakthrough Synergistic Effects of Healthy Weight Stack*

LFVN : 12.40 (+0.16%)
LifeVantage Announces Preliminary Second Quarter Revenue Results and Raises Fiscal 2025 Revenue Guidance

LFVN : 12.40 (+0.16%)
LifeVantage to Participate in the 27th Annual ICR Conference

LFVN : 12.40 (+0.16%)
LifeVantage to Participate in the Water Tower Fireside Chat Series

LFVN : 12.40 (+0.16%)
LifeVantage Unveils Lip Care Favorite Back for Cyber Monday

LFVN : 12.40 (+0.16%)
LifeVantage to Participate at the Sidoti Micro Cap Conference

LFVN : 12.40 (+0.16%)
Lifevantage: Fiscal Q1 Earnings Snapshot

Lifevantage: Fiscal Q1 Earnings Snapshot

LFVN : 12.40 (+0.16%)
LifeVantage Announces Financial Results for the First Quarter of Fiscal 2025

LFVN : 12.40 (+0.16%)

Business Summary

Lifevantage Corporation is a health and nutrition company. The company is the maker of Protandim(R), the Nrf2 Synergizer(R) patented dietary supplement, the TrueScience(TM) Anti-Aging Skin Care Regimen, Canine Health and the AXIO(TM) energy product line. Lifevantage Corporation is headquartered in Salt...

See More

Key Turning Points

3rd Resistance Point 14.38
2nd Resistance Point 13.90
1st Resistance Point 13.14
Last Price 12.40
1st Support Level 11.90
2nd Support Level 11.42
3rd Support Level 10.66

See More

52-Week High 27.38
Fibonacci 61.8% 18.91
Fibonacci 50% 16.30
Fibonacci 38.2% 13.69
Last Price 12.40
52-Week Low 5.22

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Unlock High-Probability Trade Setups: Master Fractals & Time Frames Like a Pro